How Do Metal Ion Levels Change over Time in Hip Resurfacing Patients? A Cohort Study
Table 3
Prospective clinical, radiographic, and biochemical evaluation of nineteen HR patients.
Code at ≠ follow-up
Gender
Age at surg.
Status*
2-year follow-up
5-year follow-up
9-year follow-up
Acetab. Ø mm
Head Ø mm
Cup inclin. angle°
HHS
UCLA scale
Cr
Co
Ni
Mo
Cr
Co
Ni
Mo
Cr
Co
Ni
Mo
(1) 3712/4567
M
52
U
■
■
■
■
1.62
0.51
0.67
0.83
1.17
0.78
0.17
0.93
56
50
58
92/97
5/6
(2) 2819/3546/4556
F
42
U
1.73
0.41
0.69
0.98
2.61
1.44
0.77
0.83
3.81
2.45
0.49
0.83
46
38
40
90/94/95
9/9/10
(3) 3561/4564
M
45
U
■
■
■
■
2.47
2.27
1.03
0.83
1.41
0.87
0.39
0.83
62
54
45
99
9/10
(4) 2808/4542
M
42
U
1.09
0.08
0.69
0.83
■
■
■
■
1.30
0.53
0.2
0.97
56
50
32
100
7
(5) 3559/4546
M
50
U
■
■
■
■
1.34
0.37
0.97
0.83
0.84
0.36
0.41
0.83
62
54
48
100/98
9/7
(6) 2817/3567
M
60
U
0.82
0.53
0.79
1.04
0.88
0.55
0.73
0.83
■
■
■
■
60
54
30
100
10
(7) 2812/3464/4547
M
55
U
0.88
0.23
0.55
0.83
1.16
0.52
0.51
0.96
0.86
0.77
0.3
0.83
60
54
46
100
9/8/7
(8) 3713/4585
M
61
U
■
■
■
■
1.00
0.83
0.51
0.83
1.01
0.999
0.32
0.83
62
54
47
96/100
6/10
(9) 2894/4554
M
42
U
1.08
0.11
0.1
0.83
■
■
■
■
1.06
0.68
0.24
0.83
52
46
46
100/98
8
(10) 2830/4583
F
37
U
2.08
0.58
0.94
0.83
■
■
■
■
1.24
0.64
0.79
0.83
54
46
43
90/97
9
(11) 2882/4559
F
73
U
7.24
8.96
0.48
1.23
■
■
■
■
28.03
32.24
0.47
1.59
52
46
59
83/57
7
(12) 3664/4568
M
62
U
■
■
■
■
0.91
0.3
0.34
0.83
0.73
0.58
0.28
0.83
58
50
56
95/85
5/6
(13) 2845/4562
F
42
U
5.67
1.67
0.69
0.83
■
■
■
■
2.30
1.6
0.1
0.83
54
46
55
84/79
7
(14) 2844/3460/4544
F
57
U
2.36
0.74
0.6
0.83
1.78
1.36
0.94
0.83
0.93
0.93
0.23
0.91
48
42
42
86/90/70
6/6/3
(15) 2895/3714/4566
M
24
U
1.33
0.45
0.99
0.83
1.60
0.72
0.99
0.83
1.71
0.82
0.42
0.83
58
46
40
100/89/95
7/6/4
(16) 2713/4541
M
63
U
0.69
0.76
0.34
0.83
■
■
■
■
4.10
2.39
0.39
0.93
54
60
45
100/98
7
(17) 2816/3568†
F
59
B
2.99
1.62
0.69
1.3
2.62
2.06
0.64
**
■
■
■
■
52
50
45
90/100
7
(18) 2839/3544/4560††
F
47
U/B
2.57
0.96
0.63
0.83
4.78
2.89
0.6
**
2.98
1.53
0.61
0.83
54
46
45
100/97/69
7/7/3
(19) 2810/3558†††
M
39
U/B
1.79
0.63
0.74
0.83
4.21
2.38
0.43
**
■
■
■
■
60
54
50
100/97
8/9
Bilateral implant from 2 yrs and 5 yrs, ††one and four years after contralateral surgery, †††one year after contralateral surgery, *U: unilateral/B: bilateral, **insufficient serum for Mo.
